Embecta Corp. (EMBC)
After hours:
| Previous Close | 10.40 |
| Open | 10.40 |
| Bid | 10.28 x 200 |
| Ask | 10.32 x 200 |
| Day's Range | 10.29 - 10.58 |
| 52 Week Range | 9.93 - 32.00 |
| Volume | |
| Avg. Volume | 433,509 |
| Market Cap | 593.638M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | 10.74 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.60 (5.82%) |
| Ex-Dividend Date | Feb 27, 2024 |
| 1y Target Est | N/A |
- GlobeNewswire
embecta to Report Fiscal Second Quarter 2024 Financial Results
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, May 9, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live
- GlobeNewswire
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at the Advanced Technologies & Treatments for Diabetes (ATTD) international conference. This event is scheduled for Wednesday, March 6, at 10:40 a.m. Eastern Standard Time / 14:40 Central European Time. Additionally, six embecta-sponsored abstracts focusing on injection and insulin
- GlobeNewswire
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2023. "Building on our performance during 2023, embecta delivered strong results for the first quarter of 2024," said Devdatt (Dev) Kurdikar, Chief Executive Officer of embecta. "During the first quarter, I am pleased to report that we transitioned approximately sixty percent o
